Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People diagnosed with advanced melanoma (stage III or stage IV that cannot be removed by surgery), classified according to a standard medical staging system
- People who received a type of cancer treatment called immunotherapy (specifically treatments targeting PD-1 and/or CTLA-4 pathways) with the aim of curing or controlling the disease
- People whose treatment and follow-up care took place at the Dermatology Department of the Strasbourg University Hospitals
- People whose immunotherapy began between January 1, 2013, and December 31, 2021
Who may not be able to join:
- People whose melanoma originated in the eye (specifically the choroid, a layer inside the eye)
- People who received immunotherapy as a preventative or follow-up treatment after surgery, rather than as a primary treatment (confirm with trial site)
- People who had less than 3 months of follow-up care after starting immunotherapy
- People whose treatment was changed before their first scheduled check-up or assessment
- People whose treatment and follow-up care took place at a department other than the Dermatology Department of the Strasbourg University Hospitals
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 33 3 88 11 66 27
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Response Evaluation Criteria in Solid Tumors
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.